BioAge Labs BIOA
NASDAQ BIOA
$9.70 -1.05 (-9.77%)
As of: Aug 20, 2026 · 3:57 PM EDT

BioAge Labs (BIOA) EBT Margin Growth (1y) (2026)

BioAge Labs (BIOA) EBT Margin Growth (1y) (2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -1,585.00
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -177.00
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -27.00
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn -356.00
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 436.00
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -629.00
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 208.00
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 BioAge Labs 434.04 Mn 434.04 Mn -14.23 Mn -16,302.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -553,404.00
Mar 31, 2026 9,702.00